Upcoming dinner program at Vivace's next month. 

Clinical Evidence Supporting the Role of DOPTELET® (avatrombopag) for Adult Patients with Chronic Immune Thrombocytopenia (ITP) Who Have Had an Insufficient Response to a Previous Treatment
RSVP by. 11/17/2020to: Email:
rhoward@dova.com
Phone: 520-609-4941
Friday, November 20, 2020 Program begins: 6:00 PM MST